Achieve Life Sciences (ACHV) Change in Acquisitions & Divestments (2010 - 2026)

Achieve Life Sciences (ACHV) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $15.4 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 4.87% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.6 million (up 15.42% YoY) and the FY2025 annual result came in at $30.9 million, up 17.33% from the prior year.
• Change in Acquisitions & Divestments grew to $15.4 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $15.4 million in Q1 2026 to a low of $2.8 million in Q3 2025.
• A 3-year average of $9.8 million and a median of $10.1 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments sank 54.14% — and 2026, when it gained 4.87%.
• Tracing ACHV's Change in Acquisitions & Divestments over 3 years: stood at $12.6 million in 2024, then slumped by 54.14% to $5.8 million in 2025, then surged by 166.07% to $15.4 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $15.4 million (Q1 2026), $5.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.